Richard S. Blumberg, M.D., is Director of the Laboratory of Mucosal Immunology at the Brigham and Women's Hospital, Co-director of the Harvard Digestive Diseases Center, and Professor of Medicine at Harvard Medical School. A senior physician and Chief of Gastroenterology, Hepatology and Endoscopy at the Brigham and Women's Hospital, he also serves as a consultant at the Dana-Farber Cancer Institute. Internationally recognized in the areas of mucosal immunology and IBD pathogenesis, his translational work spawned a new class of antibody-based therapeutics (currently in clinical trials globally). He is a member of the American Society of Clinical Investigation and the Association of American Physicians, a Past-President of the Society of Mucosal Immunology, a past chair of the National Scientific Advisory Committee of the CCFA, and an active member of the AGA (and has served on AGA committees). He has served as associate editor, guest editor and member of the editorial board of Gastroenterology.
Dr. Blumberg received his M.D. from Jefferson Medical College of the Thomas Jefferson University, Philadelphia, PA; served his internship, residency and assistant chief residency at NYP/Weill Cornell; completed clinical and research fellowships in infectious diseases at Massachusetts General Hospital, a research fellowship in medicine at Harvard Medical School and the Dana-Farber Cancer Institute in the Laboratory of Molecular Immunology (directed by Dr. Cox Terhorst), and a clinical fellowship in gastroenterology at the Brigham and Women's Hospital. He recently received a William Beaumont Prize for major contributions that have significantly advanced gastroenterological basic or clinical research, and has 300 peer-reviewed and non-peer-reviewed publications, books and book chapters.